Sodium 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronate(CAS: 129541-41-9)

Sodium 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronate is a crystalline compound with a molecular weight of approximately 674.2 g/mol. It has a high solubility in water and exhibits moderate reactivity in organic solvents. This compound is known for its stability under normal storage conditions and requires careful handling during synthesis and use due to its chemical reactivity.

Sodium 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronate is synthesized through a multi-step process involving bromination and chlorination of indole followed by coupling with glucopyranosiduronate. Commonly, this involves the use of bromine and chlorine with a suitable catalyst. The reaction is typically carried out in anhydrous conditions to ensure high yield and selectivity.

Sodium 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronate is utilized in the pharmaceutical industry for the development of novel drug candidates. It may also find applications in the biochemical industry, particularly in the synthesis of complex glycoconjugates and in the development of biosensors. Its unique chemical structure makes it a valuable reagent in organic synthesis and material science.

When handling Sodium 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronate, it is essential to wear appropriate personal protective equipment (PPE) such as gloves and safety goggles. The compound should be handled in a fume hood due to its potential for off-gassing. In the event of a spill, it is recommended to use appropriate absorbents and follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for safe disposal. Storage should be in a cool, dry place away from direct sunlight.